Summary
Valeritas Inc (Valeritas) is a medical technology company that develops and commercializes treatment solutions for diabetes. The company’s product includes V-Go insulin delivery device a wearable basal-bolus insulin delivery solution for patients with Type 2 diabetes. It also provides V-Go link device connectivity, h-Patch fully disposable, V-Go pre-fill device, controlled delivery technology platform, Micro-Trans microneedle array patch, and Mini-Ject needle-free injection systems, among others. Valeritas’ V-Go pre-fill device is a pre-filled insulin cartridge that helps patients to fill the cartridge. It sells products to third-party wholesalers and medical supply distributors across the US. The company operates through its manufacturing and research and development facilities located in New Jersey and Massachusetts, the US. Valeritas is headquartered in Bridgewater, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
Valeritas Inc (Valeritas) is a medical technology company that develops and commercializes treatment solutions for diabetes. The company’s product includes V-Go insulin delivery device a wearable basal-bolus insulin delivery solution for patients with Type 2 diabetes. It also provides V-Go link device connectivity, h-Patch fully disposable, V-Go pre-fill device, controlled delivery technology platform, Micro-Trans microneedle array patch, and Mini-Ject needle-free injection systems, among others. Valeritas’ V-Go pre-fill device is a pre-filled insulin cartridge that helps patients to fill the cartridge. It sells products to third-party wholesalers and medical supply distributors across the US. The company operates through its manufacturing and research and development facilities located in New Jersey and Massachusetts, the US. Valeritas is headquartered in Bridgewater, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Valeritas Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Valeritas Inc Company OverviewValeritas Inc Company Snapshot
Valeritas Inc Pipeline Products and Ongoing Clinical Trials Overview
Valeritas Inc – Pipeline Analysis Overview
Valeritas Inc - Key Facts
Valeritas Inc - Major Products and Services
Valeritas Inc Pipeline Products by Development Stage
Valeritas Inc Ongoing Clinical Trials by Trial Status
Valeritas Inc Pipeline Products Overview
V-Go Prefill Device
V-Go Prefill Device Product Overview
V-Go SIM
V-Go SIM Product Overview
V-Go Wearable Insulin Delivery Device
V-Go Wearable Insulin Delivery Device Product Overview
V-Go Wearable Insulin Delivery Device Clinical Trial
Valeritas Inc - Key Competitors
Valeritas Inc - Key Employees
Valeritas Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Valeritas Inc, Recent Developments
May 29, 2019: Valeritas to participate in the American Diabetes Association’s 79th Scientific Sessions; company reiterates second quarter and full-year 2019 revenue guidance
May 28, 2019: American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019
May 22, 2019: Valeritas’ V-Go demonstrates positive impact in diabetes quality performance measures in an older adult population
Apr 26, 2019: Valeritas’ V-Go Wearable Insulin Delivery Device demonstrates a reduction in A1c levels by 1.5 and total daily insulin dosage by 14%
Apr 08, 2019: Valeritas’ V-Go Wearable Insulin Delivery Device demonstrates 24% reduction in total daily insulin dosage and lower A1C compared to standard insulin treatment
Mar 28, 2019: Valeritas announces V-Go distribution agreement in Israel
Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
Feb 21, 2019: Switching to Valeritas’ V-Go Wearable Insulin Delivery Device from Insulin Pen Devices for Basal-Bolus Therapy improved glycemic control with less insulin
Jan 14, 2019: Valeritas announces V-Go received preferred status on OptumRx Formularies
Jan 03, 2019: Valeritas announces V-Go is preferred on Humana Part D Formularies
Appendix
Methodology
About Us
Contact Us
Disclaimer
List of Tables
Valeritas Inc Pipeline Products and Ongoing Clinical Trials Overview
Valeritas Inc Pipeline Products by Equipment Type
Valeritas Inc Pipeline Products by Indication
Valeritas Inc Ongoing Clinical Trials by Trial Status
Valeritas Inc, Key Facts
Valeritas Inc, Major Products and Services
Valeritas Inc Number of Pipeline Products by Development Stage
Valeritas Inc Pipeline Products Summary by Development Stage
Valeritas Inc Ongoing Clinical Trials by Trial Status
Valeritas Inc Ongoing Clinical Trials Summary
V-Go Prefill Device - Product Status
V-Go Prefill Device - Product Description
V-Go SIM - Product Status
V-Go SIM - Product Description
V-Go Wearable Insulin Delivery Device - Product Status
V-Go Wearable Insulin Delivery Device - Product Description
V-Go Wearable Insulin Delivery Device - Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go in Patients with Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices: TITRATE
V-Go Wearable Insulin Delivery Device - Efficacy and Safety Comparison Between U-100 Regular Human Insulin and Rapid Acting Insulin When Delivered by VGo Wearable Insulin Delivery in Type 2 Diabetes
Valeritas Inc, Key Employees
Valeritas Inc, Other Locations
Glossary
List of Figures
Valeritas Inc Pipeline Products by Equipment Type
Valeritas Inc Pipeline Products by Development Stage
Valeritas Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Tandem Diabetes Care Inc
- PharmaJet Inc
- Owen Mumford Inc
- DexCom Inc
